false
Hamburger Menu
Catalog
On Demand: Outsmarting the Heart: A Novel Device T ...
On Demand: Outsmarting the Heart: A Novel Device Therapy Targeting the Neurohormonal Pathways in Heart Failure Patients
Webinar Description
A major burden on patient quality of life and the healthcare system in the U.S., heart failure (HF) is associated with high morbidity and mortality rates. Despite the use of guideline-directed medical therapy (GDMT), many HF patients may experience worsening symptoms and disease progression. Barostim is a novel device therapy that works with GDMT and targets the neurohormonal pathways responsible for HF progression and symptoms. Join this webinar to learn more about how Barostim can help your HF patients.
Speakers
Bonnie Handke, Senior Vice President of Patient Access
Jim Kreiner, MHA, Director, Cardiovascular Operations, Prisma Heart Hospital
Dr. Patrick McCann, Physician, Prisma Heart Hospital
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
No Credit Offered
×
On Demand: Outsmarting the Heart: A Novel Device Therapy Targeting the Neurohormonal Pathways in Heart Failure Patients Course List
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Forgot Password
×
Please select your language
1
English